A german firm is making strides with a new drug for pain.
For more on this see Rammes and Shierloh IDrugs. 2006 Feb;9(2):128-35 The drug is also being studied for its effect on Alzhemer’s and drug and alchohol dependence. We will make more available as it becomes available to us. Early drug research is often proprietary with companies reluctant to reveal all.
Merz laboratories are conducting studies on a new and potent NMDA antagonist as pertaining to pain and other matters. This is the latest in a chain of NMDA blockers and may well gain a role in the treatment of neuropathic pain.
